Made by SterisWHO-GMP

Conaris Sb 130

by Steris Healthcare Pvt. Ltd.

Be the first to review

Itraconazole 130 mg

CONARIS SB 130 (Itraconazole 130 mg Super Bioavailable Capsules), manufactured by Steris Healthcare, is an advanced broad-spectrum triazole antifungal medication. Utilizing innovative Super Bioavailable (SB) technology, it is indicated for the treatment of severe, systemic, and recalcitrant fungal infections—including dermatophytosis, candidiasis, aspergillosis, and onychomycosis—delivering superior therapeutic absorption at a reduced daily dose.

View medicine information ↓
Choose a pack
₹167.34₹239.0630% offinclusive of all taxes
Subscribe & save 5%Refill on your schedule · skip or cancel anytimeSave ₹8.37 every delivery
Set up autopay

Delivery estimate appears here

ManufacturerSteris Healthcare Pvt. Ltd.
Manufacturing qualityWHO-GMP verified
Expiry policyMinimum 3 months
ReviewedClinical review pending

Medicine information

Uses & overview

CONARIS SB 130 by Steris Healthcare contains 130 mg of Itraconazole formulated with Super Bioavailable (SB) technology. Standard Itraconazole formulations suffer from erratic gastric absorption and depend heavily on stomach acid and food intake. CONARIS SB 130 overcomes these limitations by delivering enhanced aqueous solubility and predictable systemic bioavailability, allowing for lower dosing while maintaining high drug concentrations in target tissues like skin, nails, and mucous membranes. Key Ingredients & Clinical Benefits: Itraconazole SB (130 mg): A potent broad-spectrum triazole antifungal that inhibits the fungal cytochrome P450-dependent enzyme 14$\alpha$-demethylase. This blocks the conversion of lanosterol to ergosterol—an essential component of the fungal cell membrane—leading to membrane disruption, increased permeability, and fungal cell death. Key Uses & Clinical Benefits: Super Bioavailable Technology: Delivers therapeutic tissue levels comparable to higher doses of conventional Itraconazole (e.g., 200 mg), offering higher efficacy with lower drug load. Gastric Acid Independent Absorption: Unlike traditional Itraconazole, SB technology allows consistent absorption regardless of stomach acidity or concurrent antacid use. Broad-Spectrum Antifungal Coverage: Highly effective against dermatophytes (Tinea corporis, Tinea cruris, Tinea pedis), yeasts (Candida species), and systemic fungi (Aspergillus, Blastomyces, Histoplasma). Treatment of Recalcitrant Dermatophytosis: Ideal for hard-to-treat, chronic, or recurrent fungal skin infections and severe nail fungal infections (onychomycosis). High Tissue Affinity: Accumulates in keratin-rich tissues (skin, hair, and nails) where it remains active long after the treatment course is completed.

How to use

Take 1 capsule of CONARIS SB 130 once or twice daily, or strictly as prescribed by your dermatologist or physician. Swallow the capsule whole with a glass of water. Do not crush, chew, or open the capsule. While SB technology reduces food dependencies, taking the capsule with or after a meal is recommended for maximum comfort and optimal absorption. Complete the full prescribed course even if symptoms resolve early.

Storage

Store in a cool, dry, and dark place away from direct sunlight, heat, and moisture. Store at a controlled room temperature below 30°C. Protect from humidity. Keep out of reach and sight of children.

Important guidance

Safety advice

Check with your doctor
AlcoholConsult your doctor

Avoid drinking alcohol while taking CONARIS SB 130, as alcohol can increase the risk of liver toxicity and central nervous system side effects such as dizziness.

PregnancyConsult your doctor

CONARIS SB 130 is strictly contraindicated during pregnancy (except in life-threatening systemic fungal cases). It can cause severe fetal harm and congenital abnormalities. Effective contraception must be used during and for one menstrual cycle after stopping treatment.

BreastfeedingConsult your doctor

Itraconazole passes into human breast milk. Do not take CONARIS SB 130 while nursing unless explicitly advised by your physician, who may recommend alternative treatment or discontinuation of breastfeeding.

DrivingConsult your doctor

Exercise caution when driving or operating machinery. CONARIS SB 130 may occasionally cause dizziness, visual disturbances, or hearing loss in some individuals.

KidneyConsult your doctor

Use with caution in patients with renal impairment. Although oral Itraconazole bioavailability may be altered in kidney disease, dose adjustments should be monitored by a physician.

LiverConsult your doctor

Contraindicated in patients with active liver disease or underlying hepatic impairment. Baseline Liver Function Tests (LFTs) and periodic monitoring during extended therapy are strongly recommended.

Clinical review pending

This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.

Customer feedback

Ratings & reviews

Be the first to review this product.

Loading reviews…

Write a review

Your feedback helps other customers make informed choices.

0/3000 charactersChecking your sign-in status…

Frequently viewed together

Rx · H
Conaris T 200 product pack

Conaris T 200

For 10 Tablet

Terbinafine 250 mg + Itraconazole 200 mg

No reviews
₹142.80₹204.0030% off
Prescription required before dispatch
Rx · H
Tedizoline 200 product pack

Tedizoline 200

For 6 Tablets

Tedizolid Phosphate 200 mg

No reviews
₹805.00₹1,150.0030% off
Prescription required before dispatch
Rx · H
Viga Bright Gel product pack

Viga Bright Gel

10*1*22 GM · TUBE
No reviews
₹87.00₹125.0030% off
Prescription required before dispatch
Rx · H
Conaris 100 product pack

Conaris 100

For 10 Capsules

Itraconazole 100 mg

No reviews
₹114.84₹164.0630% off
Prescription required before dispatch

Let’s help you order

Speak to our team about medicine availability, prescriptions or your order.

Opens your device’s calling app.